Description
Chronic Leukemias and Lymphomas, Softcover reprint of the original 1st ed. 2003
Biology, Pathophysiology, and Clinical Management
Current Clinical Oncology Series
Coordinator: Schiller Gary J.
Language: EnglishSubject for Chronic Leukemias and Lymphomas:
Keywords
Staging; biology; cell; leukemia; lymphoma; oncology; pathophysiology; pharmacology; physiology
Chronic Leukemias and Lymphomas
Publication date: 02-2013
342 p. · 15.2x22.9 cm · Paperback
Publication date: 02-2013
342 p. · 15.2x22.9 cm · Paperback
Chronic leukemias and lymphomas: clinical management
Publication date: 10-2002
342 p. · 15.5x23.5 cm · Hardback
Publication date: 10-2002
342 p. · 15.5x23.5 cm · Hardback
Description
/li>Contents
/li>Comment
/li>
In Chronic Leukemias and Lymphomas: Clinical Management, a panel of recognized experts in hematological oncology describe the unique biological features of indolent hematologic neoplasms, providing powerful insight into their clinical manifestation, highlighting potential targets for novel therapies, and distinguishing these disorders from aggressive lymphoma and Hodgkin's disease. In their integrated surveys of these chronic myeloproliferative and lymphoproliferative disorders, the authors emphasize such unique entities as prolymphocytic leukemias and cutaneous lymphomas. Special emphasis is given to the mechanisms of disease progression with authoritative insights into the promising new era of antineoplastic pharmacology.
1 Chronic Leukemias: History, Epidemiology, and Risk Factors.- 2 Chronic Lymphocytic Leukemia: Diagnosis and Management.- 3 Hairy Cell Leukemia: Biology, Diagnosis, and Treatment.- 4 Prolymphocytic Leukemias.- 5 Chronic Myeloid Leukemia.- 6 Sézary Syndrome: The Redefinition of a Clinico-Pathologic Entity and its Implication for Staging, Prognosis, and Treatment.- 7 Large Granular Lymphocyte Proliferative Diseases.- 8 Myeloproliferative Syndromes.- 9 Advances in the Biology and Treatment of Multiple Myeloma.- 10 Low-Grade Lymphoma.- 11 Aggressive Large-Cell Lymphomas.- 12 Hodgkin’s Disease.
Includes supplementary material: sn.pub/extras
© 2024 LAVOISIER S.A.S.